NYSE CONTENT ADVISORY: PRE-MARKET UPDATE + NYSE ACCEPTS MEDAL OF HONOR SOCIETY AWARD
NEW YORK, March 6, 2025 /PRNewswire/ -- The New York Stock Exchange…
BostonGene to Showcase Multi-Modal AI-Powered Platform at the 22nd Annual Meeting of the Japanese Society of Medical Oncology
Advancing Precision Oncology with AI-Driven Multiomics for Optimized Therapy Selection and Improved…
Animal charity Humane Society International India to become “Humane World for Animals” to better encompass mission
Organization launches a new global integrated marketing campaign featuring exclusive music from…
Top 10 Dynamic Personalities Empowering Indian Society
Unveiled by Kiteskraft Productions LLP CHANDIGARH, India, Jan. 29, 2025 /PRNewswire/ --…
Stanford University Libraries assume stewardship of the California Historical Society Collection
PALO ALTO, Calif. and SAN FRANCISCO, Jan. 28, 2025 /PRNewswire/ -- Stanford University…
MiNA Therapeutics Presents New Pre-Clinical Data from Lead Sickle Cell Disease Program at the American Society of Hematology Annual Meeting
MTL-HBG drug candidate demonstrated best-in-class activity and safety in pre-clinical models Data…
Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting
December 07, 2024 12:00 ET | Source: Y-mAbs Therapeutics, Inc. NEW YORK,…
AM Best Downgrades Issuer Credit Rating of Gleaner Life Insurance Society; Maintains Under Review With Developing Implications Status on Credit Ratings
OLDWICK, N.J.--(BUSINESS WIRE)--#insurance--AM Best has downgraded the Long-Term Issuer Credit Rating to…
Rakovina Therapeutics Announces Upcoming Poster Presentation at the 29th Annual Society for Neuro-Oncology Meeting in Houston, Texas
November 20, 2024 16:30 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology
November 15, 2024 17:52 ET | Source: Protara Therapeutics NEW YORK, Nov.…